Please login to the form below

Not currently logged in
Email:
Password:

Roche's Julie Warner joins Boyds

She takes up appointment as an associate director at the drug development consultancy

edit-Julie-Warner-Boyds-0914UK-based drug development consultancy Boyds has appointed Julie Warner as associate director within its regulatory affairs team.

She has previously held positions at Clovis Oncology UK, Genzyme and Gregory Fryer Associate, and was most recently senior regulatory programme manager at Roche.

The firm hopes Warner's ten years of experience in EU and US regulatory affairs will further strengthen the team, where she will work closely with Robin Henderson, director of regulatory affairs.

Commenting on her new position, Warner said: “The team has an enviable reputation for its long-standing, trusted relationships with regulatory authorities. I look forward to adding to the depth of experience at Boyds and working with clients to provide the regulatory affairs support needed to facilitate the fast and efficient development of their products."

Alan Boyd, CEO and founder of Boyds, said: “Dr Warner's appointment is excellent news for Boyds. Julie brings a wealth of expertise as well as a special interest in orphan drugs and will be a welcome addition to the team.

"I am proud of our reputation for regulatory affairs support. Clients appreciate our ability to not only provide strategic input, but also assistance in the preparation of regulatory documentation to support their activities and guidance through the sometimes complex procedures to help bring their product to the market place."

Warner is also a member of the editorial panel for the professional journal of The Organisation for Professionals in Regulatory Affairs (TOPRA), the Regulatory Rapporteur.

24th September 2014

From: Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...